Too good to be brew! DMT – the potent psychedelic in Ayahuasca – treats depression after a SINGLE dose, cutting-edge clinical trial shows

January 25, 2023 · Daily Mail UK

DMT — the most potent psychedelic known to man —  treats people with severe depression after a single dose, a cutting-edge clinical trial suggests.

Up to six in ten who received a single dose of DMT intravenously before therapy were declared depression-free three months later.

And three in 10 participants were declared depression-free two weeks after one session, compared to one in ten in the placebo group who just had therapy on its own.

N,N-Dymethyltriptamine (DMT) has received the backing of celebrities such as Joe Rogan and is growing in popularity as an alternative to harsh antidepressants. Most recently, Prince Harry admitted using ayahuasca to help him heal the trauma he felt after the death of his mother.

DMT is the natural psychedelic in ayahuasca, a potent brew widely used by tribal societies widely in the Amazon basin, where it is considered a ‘wisdom’ plant that allows entry into the spiritual world.

DMT and ayahuasca are part of a wave of psychedelics, along with psilocybin mushrooms and ketamine, that were dismissed as hippy drugs but are now being explored by scientists as powerful therapeutics.

The latest study was carried out in 2021 by Small Pharma, a biotech company based in Canada.  

It looked at 34 male and female participants with moderate or severe depression.

In the first part of the trial, 17 participants received 21.5mg of DMT, about half of a typical smoked dose.

They received the drug via an IV drip for 10 minutes, which induced a 20-30 minute psychedelic experience, followed by a therapy session immediately after to help them make sense of it.

The other 17 patients only received therapy.

Independent reviewers, who did not know what treatment participants were receiving, rated people’s depression using the Montgomery-Asberg Depression Rating scale (MADRS) at the start of the trial and then one, two and 12 weeks later. 

Two weeks after having the treatment, the DMT group’s depression scores were 7.4 points less than the placebo group, showing a statistically significant reduction in depressive symptoms compared to the placebo.

And three months after receiving treatment, symptoms had dropped even further – the total average reduction in MADRS scores after one dose of DMT was 15.4 points.

Six in ten of those who received a single dose of DMT were also declared depression-free three months later.

This was defined as having a MADRS score of ten or less.

Dr David Erritzoe, clinical psychiatrist at Imperial College London and chief investigator of the study said: ‘The results are exciting for the field of psychiatry. We now have the first evidence that DMT, combined with supportive therapy, may be effective for people suffering from MDD. 

‘For patients who are unfortunate to experience little benefit from existing antidepressants, the potential for rapid and durable relief from a single treatment, as shown in this trial, is very promising.’

Until now, DMT’s therapeutic benefits have been mainly anecdotal, alongside evidence which showed the drug also carries the risk of long-lasting negative effects on mental health

Scientific details on what exactly DMT does to the brain are scant, but research suggests there are increased ‘utilization rates’ of monoamines within the amygdala, which increases the intensity of memories.

There is also increased blood flow to the insula, which could be responsible for users’ increased self-understanding.

This is thought to make therapy more effective, as people can confront their trauma with less fear.  (Full Story)

In categories:Medical Psychedelics
Next Post

Oregon’s legal psilocybin program begins, but services are not yet available

While national headlines might make it sounds like psychedelic mushrooms are now available for adults in Oregon, that’s not the case. Oregon’s legal therapeutic psilocybin program officially began on Jan. 2, but there are currently no licensed facilities, facilitators or even…
Previous Post

The Cannabis vs. Viagra Debate - Which is Better for Sexual Health?

Viagra is the brand name of sildenafil, a class of drugs that are designed for the treatment of erectile dysfunction (ED). Men who suffer from ED struggle with starting and maintaining their erections. Depending on the case, it may be a short-term…
Random Post

Uruguay Ships 1,000+ Pounds Of Cannabis To The U.S.: Country’s Ambassador Weighs In

Uruguay, the first country in the world to legalize cannabis for adult use, is now exporting low-THC cannabis, or hemp, to the United States. According to information procured exclusively ahead of an official announcement, CEND, a global provider of customized…
Random Post

Oklahoma Bureau of Narcotics Has Shut Down 800+ Illegal Cannabis Farms Over Last Two Years

Over the last two years, the Oklahoma Bureau of Narcotics (OBN) has shut down more than 800 unlawful cannabis farms operating under the guise of the state’s medical cannabis law, KFOR reports. The crackdowns have led to more than 200 arrests and…
Random Post

Don't Like Unions, Make a Fake One Up! - California Cannabis Companies Create Fake Unions to Cut Labor Costs

According to state regulators on Monday, a dozen cannabis businesses in California, including the collapsed distribution giant Herbl, are facing the possibility of license revocation. As first reported by MJ BIZ, these businesses had previously signed agreements with a labor union…
Random Post

Smartest Guys in the Room Go Belly Up in Canada - Fire and Flower Files for Creditor Protection

Fire and Flower Throw in the Towel, Citing Significant Losses An initial order for creditor protection has been granted by a Canadian court to Fire & Flower Holdings and its cannabis-related businesses due to significant net losses of more than $150 million…